Emergent Biosolutions

This study tested a new anthrax vaccine called AV7909 in nearly 3,700 healthy adults to see if it works consistently across different batches and is safe. The vaccine is meant to protect people after they have been exposed to anthrax bacteria. Researchers compared the immune resp…

This study looked at whether giving an anthrax vaccine (AV7909) along with antibiotics (ciprofloxacin or doxycycline) changes how the body handles the drugs or the vaccine. It involved 210 healthy adults aged 18 to 45. The goal was to ensure the vaccine and antibiotics can be use…

This early-stage study tested a new naloxone nasal spray device in 24 healthy adults to see how well it delivers the drug and if it's safe. Naloxone is a life-saving medicine that reverses opioid overdoses. The study compared the new device to an existing one, measuring drug leve…